Global medicine use and spending forecast 2024-2028: a Malaysian perspective on emerging trends and opportunities / June Choon Wai Yee

With the end of the COVID-19 public health emergency in 2023, global health focus has shifted towards the prevention and treatment of both communicable and non-communicable diseases. This shift has significant implications for countries like Malaysia, where the healthcare system is evolving to meet the increasing demand for innovative therapies. The past decade has seen the introduction of breakthrough therapies across multiple diseases, significantly transforming patient care. As a result, the forecast for global medicine use and spending through 2028 has been revised upward, despite a notable decrease in the projected demand for COVID-19 vaccines and therapeutics.